Committee overview & Scientific Chairs

Congress Committees

Committee overview

Local Organising Committee (LOC)

  • Evelien Roos - Congress President
  • Charlotte Lenselink - Congress Vice-President & Secretary
  • Beth Morrel - Congress Treasurer
  • Wendy van Dorp - Member

Scientific Committee

  • Prof. Joop Laven, MD, PhD - Scientific Chair
  • Mireille Merckx, MD, PhD - Scientific Chair
  • Wendy van Dorp, MD, PhD
  • Charlotte Lenselink, MD, PhD
  • Beth Morrel, MD
  • Evelien Roos, MD

Sponsor Committee

  • Josine van der Heyde
  • Charlotte Lenselink
  • Evelien Roos
  • Eelco Schroor

Social Committee

  • Manja Dorman
  • Marloes de Vleeschouwer
  • Beth Morrel

PR Committee

  • Judith Dekker
  • Manja Dorman
  • Evelien Roos
  • Marian Spath

Scientific Chairs

Short CV - Prof. Joop S.E. Laven, MD, PhD
Professor of Reproductive Medicine, Erasmus Medical Centre, Rotterdam The Netherlands.

Professor Joop S.E. Laven is a professor in Obstetrics and Gynaecology and was initially trained at the University of Utrecht, The Netherlands. After Medical school he completed his Ph.D. thesis on clinical and experimental aspects of varicocele at Utrecht University in 1991. From 1991 till 1997 he continued his training at the University Medical Centre St. Radboud in Nijmegen. In 1997 he became board certified in OBGYN (FRCOG) and moved to the Erasmus Medical Centre in Rotterdam. In 2000 he became a certified subspecialist Reproductive Medicine. He is a member of ESHRE, ASRM, the Endocrine Society, the Society for Reproductive Investigation (SRI) and the Royal Dutch College of Obstetrics and Gynaecology. He is the Past-President of the Dutch Society of Reproductive Medicine.

For many years, Prof. Laven has had a particular interest in the management of polycystic ovary syndrome covering the full spectrum from the effects of the syndrome during adolescence and adult life on the menstrual cycle, fertility, body weight and cosmetic aspects. During the last decade, the research has focused on more fundamental effects that PCOS may have on quality of life and long-term health risks as well as the genetic basis of the disease. More recently he was also involved in Genome Wide Association Studies (GWAS), exploring the genetic basis of PCOS, premature ovarian insufficiency, menarche and menopause.

His clinical work focuses on women’s health, in particular reproductive endocrinology and menopause as well as on infertility treatment, ART and pregnancy outcome in infertile couples, especially women with PCOS. He is responsible for the Rotterdam Erasmus MC Reproductive Medicine Unit, which performs approximately 2400 IVF cycles per year. Prof. Laven works as a full time clinician and is currently head of the Division of Reproductive Medicine of the department of OBGYN at Erasmus MC in Rotterdam.

Prof. Laven has published over 300 peer-reviewed papers and several reviews as well as chapters in books, and has delivered over 300 lectures to international scientific audiences. Books to which he has contributed include Endocrinology, De Groot and Jameson, IVF in the complicated patient, Insulin Resistance and PCOS. He is a member of the editorial board of Human Reproduction Update, the Journal of the Endocrine Society and a past Associate Editor of Human Reproduction.

Currently he is living together with Annemarie Rietveld and he is the proud father of 4 sons: Niels, aged 34, Pim 30, Jannes 26 and Loek 22 years old. In his rare free private time you might see him fly-fishing or biking or just being lazy on Sunday afternoons listening to Van Morrison.

Short CV - Mireille Merckx, MD, PhD
Specialist in Gynaecology, Obstetrics and Andrology, Ghent, Belgium

Dr. Merckx:

  • studied at the Flemish University of Brussels,VUB, Belgium, were she graduated as a Gynaecologist.
  • has been working as an academic staff member at the “Vrouwenkliniek” of the University Hospital of Ghent since 2012
  • has a Research activity at ICRH University of Ghent, also since 2012 
  • is running a private practice.

She was clinical and academic consultant at the Saint-Pierre and Erasmus University Clinics of Brussels, Belgium, and in the Paola Children's Hospital, Antwerp, Belgium. 

Her special destinations include Clinical Obstetrics & Gynaecology, Endoscopic Surgery, Parenthood and Family Planning Agencies, Paediatric & Adolescent Gynaecology and Forensic Expertise in Sexual Abuse of adults and children.

After specializing in Paediatrics and Adolescent Gynaecology at the Necker Institute in Paris, France, Dr. Merckx became Head of the Department of Paediatric and Adolescent Gynaecology at University Hospital Saint-Pierre. She worked as a consultant in vulvo-vaginal mucosal pathology in children at the clinic of the Erasmus University of Brussels. She still works in continuing medical education and is training fellows, junior fellows and other healthcare professionals in Gynaecology. Currently, she is responsible for the department of Paediatric and Adolescent Gynaecology at the University Clinic of Ghent.

Dr. Merckx obtained a PHD degree in Medical Sciences in November 2014. Her thesis about ‘Human Papillomavirus and related disease in underage children: implications for prevention’ was fulfilled at the International Center for Reproductive Health (ICRH) Ghent University under the promotion of Prof. S. Weyers and Prof D. Vandebroeck, molecular biologist UZ Ghent, Prof. Marleen Temmerman Gynaecologist, and Prof. J. de Schepper, Paediatric Endocrinologist VUB & UZ Ghent.

Since 2008, Dr. Merckx has been active as Vice President of the Board of Directors of the Flemish Obstetrical and Gynaecological Association as well as President of their scientific committee and President of the Belgian Association of Paediatric Gynaecology. Dr. Merckx is an active member at GAMS (Group for the Abolition of Sexual Mutilation),  where she trains medics and paramedics in sexual mutilation pathology. Furthermore, she is a member of the multidisciplinary team at UZ Ghent.

Dr. Merckx is active in development of HPV vaccination in Belgium and works in a collaborative research program on HPV at the ICRH at Ghent University, Belgium. She is active in the Working Group for population screening for cervical cancer and in the Working Group on vaccination, Zika and sexual transmitted diseases at the Governmental Health institute. 

She is also a founding member of ISIDOG, the International Society of Infectious Disease in Obstetrics and Gynaecology.

She is board member of the European Society of Contraception and Reproductive Health (ESC) and of FIGIJ, the International Federation of Paediatric and Adolescent Gynaecology. 

Dr. Merckx serves as a reviewer for:

  • The journals Vaccine, the European Journal of contraception and reproductive health, the Journal of Paediatric and Adolescent Gynaecology, the Journal of Family Planning and Reproductive health, the European Journal of Cancer
  • The abstracts introduced for the European Society of Contraception Meetings
  • The Foundation Maria-Elisa and Guillaume De Beys applications as she is active in the “Koning Boudewijn Stichting”.

Dr. Merckx serves as an expert advisor in the WHO Women’s Health Department in Contraception. Furthermore, she has been a member of the steering committee of the In-choice Contraception Study Group since 2009 as well as a member of the expert group on Flexible Oral Contraceptive Regimens and LARC since 2011.

Finally, Dr. Merckx is part of the Governmental Advisory Board to establish a future consensus on HPV vaccination policy.